While liquid biopsies can offer significant advantages, there are critical factors to assess the quality of these solutions ...

Updated results of an Australian trial which used liquid biopsies to guide colon cancer treatment has confirmed no compromise ...

The global Liquid Biopsy Market is experiencing significant growth, driven by increasing cancer prevalence, advancements in ...

The global Liquid Biopsy Market, valued at US$5.9 billion in 2023, is forecasted to grow at a robust CAGR of 11.9%, reaching ...

RBC Capital initiated coverage of Exact Sciences (EXAS) with a Sector Perform rating and $52 price target while launching coverage of the ...

Dublin, Feb. 21, 2025 (GLOBE NEWSWIRE) -- The "Liquid Biopsy for Cancer Diagnostics Market Opportunities and Strategies to 2034" report has been added to ResearchAndMarkets.com's offering.

Tethis collaborates with Sheba Medical Center to advance AI-powered liquid biopsy in rectal cancer: Milan, Italy Tuesday, March 11, 2025, 13:00 Hrs [IST] Tethis S.p.A., a pioneer ...

Discover how the global rare biomarkers market is expanding at 14.4% annually, fueled by non-invasive testing.

The liquid biopsy test enables oncologists to perform comprehensive genomic profiling to inform personalized treatment decisions – all from a simple blood draw. "Labcorp Plasma Complete delivers ...

Want to invite a colleague to this FREE webinar? Fill out the form below and we'll send your colleague an invitation to the "Investigating Cell-Free DNA in Liquid Biopsy" event. Cell-free DNA (cfDNA) ...

Tethis S.p.A., a pioneer in standardized liquid biopsy platform development, and Sheba Medical Center, Israel's largest medical center consistently ranked as a Top 10 World's Best Hospital by Newsweek ...